Impact of MYD88 L265P mutation status on histological transformation of Waldenström Macroglobulinemia-Reference-Cited by-同舟云学术

Impact of MYD88 L265P mutation status on histological transformation of Waldenström Macroglobulinemia

Published:2019-12-31 Issue:3 Volume:95 Page:274-281
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Zanwar Saurabh¹^ORCID,Abeykoon Jithma P.²^ORCID,Durot Eric³^ORCID,King Rebecca⁴,Perez Burbano Gabriela E.⁵,Kumar Shaji²,Gertz Morie A.²^ORCID,Quinquenel Anne³^ORCID,Delmer Alain³,Gonsalves Wilson²^ORCID,Cornillet‐Lefebvre Pascale⁶,He Rong⁴,Warsame Rahma²^ORCID,Buadi Francis K.²,Novak Anne J.²,Greipp Patricia T.⁷,Inwards David²,Habermann Thomas M.²,Micallef Ivana²,Go Ronald²,Muchtar Eli²,Kourelis Taxiarchis²^ORCID,Dispenzieri Angela²^ORCID,Lacy Martha Q.²,Dingli David²,Nowakowski Grzegorz²,Thompson Carrie A.²,Johnston Patrick²,Thanarajasingam Gita²,Bennani N. Nora²,Witzig Thomas E.²^ORCID,Villasboas Jose²,Leung Nelson²^ORCID,Lin Yi²,Kyle Robert A.²,Rajkumar S. Vincent²^ORCID,Ansell Stephen M.²^ORCID,Le‐Rademacher Jennifer G.⁵,Kapoor Prashant²^ORCID

Affiliation:

1. Department of Internal MedicineMayo Clinic Rochester Minnesota

2. Division of Hematology, Department of Internal MedicineMayo Clinic Rochester Minnesota

3. Department of HematologyUniversity Hospital of Reims and UFR Médecine Reims France

4. Department of Laboratory Medicine and PathologyMayo Clinic Rochester Minnesota

5. Division of Biomedical Statistics and Informatics, Department of Health Sciences ResearchMayo Clinic Rochester Minnesota

6. Laboratory of HematologyUniversity Hospital of Reims and UFR Médecine Reims France

7. Division of Laboratory GeneticsMayo Clinic Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25697

Reference32 articles.

1. Diagnosis and Management of Waldenström Macroglobulinemia

2. Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders

3. Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

4. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

5. Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Profiling of Small Mature B Cell Lymphomas; New Insights on Diagnosis and Treatment;Advances in Molecular Pathology;2024-08

2. High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia;Blood;2024-06-27

3. In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation;Annals of Hematology;2023-11-11

4. New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia;Expert Review of Hematology;2023-11-02

5. DLBCL arising from indolent lymphomas: How are they different?;Seminars in Hematology;2023-11